Contents

Current Pharmaceutical Design, Volume 19 - Number 33

Editorial (Thematic Issue: Novel Targets and Biomarkers for Anti-atherosclerotic Therapy)

, 19(33): 5837 - 5839

Yuri V Bobryshev


DOI: 10.2174/1381612811319330001




Emerging Anti-inflammatory Therapies for Atherosclerosis

, 19(33): 5840 - 5849

François Roubille, Ekaterini A. Kritikou, Camille Roubille and Jean-Claude Tardif


DOI: 10.2174/13816128113199990351




T Cell-based Therapies for Atherosclerosis

, 19(33): 5850 - 5858

Daniel F.J. Ketelhuth, Anton Gisterå, Daniel K. Johansson and Göran K. Hansson


DOI: 10.2174/1381612811319330003




Novel Monocyte Biomarkers of Atherogenic Conditions

, 19(33): 5859 - 5864

Alexei Gratchev, Ilja Ovsiy, Ioannis Manousaridis, Vladimir Riabov, Alexander Orekhov and Julia Kzhyshkowska


DOI: 10.2174/1381612811319330004




Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions

, 19(33): 5865 - 5872

Howar S. Kruth


DOI: 10.2174/1381612811319330005




Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy

, 19(33): 5873 - 5882

Ilse Van Brussel, Dorien M. Schrijvers, Emily A. Van Vré and Hidde Bult


DOI: 10.2174/1381612811319330006




Dendritic Cells in Atherosclerosis

, 19(33): 5883 - 5890

Siân P. Cartland and Wendy Jessup


DOI: 10.2174/1381612811319330007




Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet

, 19(33): 5891 - 5896

Jingjing Zhao, Hong Zhu, Shijun Wang, Xin Ma, Xiangwei Liu, Cong Wang, Hangtian Zhao, Shuxia Fan, Xueting Jin, Buchang Zhao, Tao Zhao, Lifu Jia, Keqiang Wang, Yunzeng Zou, Kai Hu, Aijun Sun and Junbo Ge


DOI: 10.2174/1381612811319330008




Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis

, 19(33): 5897 - 5903

Elisabet Rosas, Igor Sobenin, Alexander Orekhov, Elazer R. Edelman and Mercedes Balcells


DOI: 10.2174/1381612811319330010




Cyclophilins in Atherosclerosis: A New Therapeutic Target?

, 19(33): 5904 - 5908

Michael Bukrinsky, Alexander Orekhov, Michael Ditiatkovski and Dmitri Sviridov


DOI: 10.2174/1381612811319330009




Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

, 19(33): 5909 - 5928

Alexander N. Orekhov


DOI: 10.2174/1381612811319330011




Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis

, 19(33): 5929 - 5941

Marten Siemelink, Sander van der Laan, Leo Timmers, Imo Hoefer and Gerard Pasterkamp


DOI: 10.2174/13816128113199990371




Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications

, 19(33): 5942 - 5953

Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov and Alexander N. Orekhov


DOI: 10.2174/1381612811319330013




Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

, 19(33): 5954 - 5962

Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov and Alexander N. Orekhov


DOI: 10.2174/1381612811319330014




The Complementary Roles of Imaging and ‘Omics’ for Future Anti-Atherosclerotic Drug Development

, 19(33): 5963 - 5971

Rishi Puri and Steven E. Nissen


DOI: 10.2174/13816128113199990365




Editorial (Thematic Issue: Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of Treatment)

, 19(33): 5972 - 5973

Antonino Tuttolomondo


DOI: 10.2174/1381612811319330016




Anderson-Fabry Disease: A Multiorgan Disease

, 19(33): 5974 - 5996

Antonino Tuttolomondo, Rosaria Pecoraro, Irene Simonetta, Salvatore Miceli, Antonio Pinto and Giuseppe Licata


DOI: 10.2174/13816128113199990352




Fabry Disease and Cardiovascular Involvement

, 19(33): 5997 - 6008

Aris Anastasakis, Efstathios Papatheodorou and Alexandros Klavdios Steriotis


DOI: 10.2174/13816128113199990353




Gastroenterological Complications of Anderson-Fabry Disease

, 19(33): 6009 - 6013

Piotr Buda, Janusz Ksi azyk and Anna Tylki-Szyma ska


DOI: 10.2174/13816128113199990347




Neurological Complications of Anderson-Fabry Disease

, 19(33): 6014 - 6030

Antonino Tuttolomondo, Rosaria Pecoraro, Irene Simonetta, Salvatore Miceli, Valentina Arnao, Giuseppe Licata and Antonio Pinto


DOI: 10.2174/13816128113199990387




Cutaneous Complications of Anderson-Fabry Disease

, 19(33): 6031 - 6036

Giuseppe Pistone, Daniele Rizzo and Maria Rita Bongiorno


DOI: 10.2174/13816128113199990359




Anderson-Fabry Disease in Children

, 19(33): 6037 - 6045

Simona Sestito, Ferdinando Ceravolo and Daniela Concolino


DOI: 10.2174/13816128113199990345




Renal Complications of Fabry Disease

, 19(33): 6046 - 6050

Nikolina Basic-Jukic, Petar Kes, Marijana Coric and Vanja Basic-Kes


DOI: 10.2174/13816128113199990346




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science